-
1
-
-
11144354339
-
Prevalence of age-related macular degeneration in the United States
-
Friedman DS, O'Colmain BJ, Munoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004;122:564-572.
-
(2004)
Arch Ophthalmol
, vol.122
, pp. 564-572
-
-
Friedman, D.S.1
O'Colmain, B.J.2
Munoz, B.3
-
2
-
-
21044453724
-
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration
-
Hageman GS, Anderson DH, Johnson LV, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 2005;102:7227-7232.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 7227-7232
-
-
Hageman, G.S.1
Anderson, D.H.2
Johnson, L.V.3
-
3
-
-
3342974773
-
Monocyte activation in patients with age-related macular degeneration: A biomarker of risk for choroidal neovascularization?
-
Cousins SW, Espinosa-Heidmann DG, Csaky KG. Monocyte activation in patients with age-related macular degeneration: a biomarker of risk for choroidal neovascularization? Arch Ophthalmol 2004;122:1013-1018.
-
(2004)
Arch Ophthalmol
, vol.122
, pp. 1013-1018
-
-
Cousins, S.W.1
Espinosa-Heidmann, D.G.2
Csaky, K.G.3
-
4
-
-
0025321591
-
Autoantibodies to retinal astrocytes associated with age-related macular degeneration
-
Penfold PL, Provis JM, Furby JH, Gatenby PA, Billson FA. Autoantibodies to retinal astrocytes associated with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1990;228:270-274.
-
(1990)
Graefes Arch Clin Exp Ophthalmol
, vol.228
, pp. 270-274
-
-
Penfold, P.L.1
Provis, J.M.2
Furby, J.H.3
Gatenby, P.A.4
Billson, F.A.5
-
5
-
-
17844364666
-
Cutting edge: In vivo blockade of human IL-2 receptor induces expansion of CD56(bright) regulatory NK cells in patients with active uveitis
-
Li Z, Lim WK, Mahesh SP, Liu B, Nussenblatt RB. Cutting edge: in vivo blockade of human IL-2 receptor induces expansion of CD56(bright) regulatory NK cells in patients with active uveitis. J Immunol 2005;174:5187-5191.
-
(2005)
J Immunol
, vol.174
, pp. 5187-5191
-
-
Li, Z.1
Lim, W.K.2
Mahesh, S.P.3
Liu, B.4
Nussenblatt, R.B.5
-
6
-
-
25444435486
-
Systemic rapamycin inhibits retinal and choroidal neovascularization in mice
-
Dejneka N, Kuroki A, Fosnot J, Tang W, Tolentino M, Bennett J. Systemic rapamycin inhibits retinal and choroidal neovascularization in mice. Mol Vis 2004;10:964-972.
-
(2004)
Mol Vis
, vol.10
, pp. 964-972
-
-
Dejneka, N.1
Kuroki, A.2
Fosnot, J.3
Tang, W.4
Tolentino, M.5
Bennett, J.6
-
7
-
-
33846973363
-
The treatment of multifocal choroiditis associated choroidal neo-vascularization with sirolimus (rapamycin)
-
Nussenblatt RB, Coleman H, Jirawuthiworavong G, et al. The treatment of multifocal choroiditis associated choroidal neo-vascularization with sirolimus (rapamycin). Acta Ophthalmol Scand 2007;85:230-231.
-
(2007)
Acta Ophthalmol Scand
, vol.85
, pp. 230-231
-
-
Nussenblatt, R.B.1
Coleman, H.2
Jirawuthiworavong, G.3
-
8
-
-
66149141458
-
Concentration of cytokines in the aqueous humor of patients with naive, recurrent and regressed CNV associated with AMD after bevacizumab treatment
-
Roh MI, Kim HS, Song JH, Lim JB, Koh HJ, Kwon OW. Concentration of cytokines in the aqueous humor of patients with naive, recurrent and regressed CNV associated with AMD after bevacizumab treatment. Retina 2009;29: 523-529.
-
(2009)
Retina
, vol.29
, pp. 523-529
-
-
Roh, M.I.1
Kim, H.S.2
Song, J.H.3
Lim, J.B.4
Koh, H.J.5
Kwon, O.W.6
-
10
-
-
21244450029
-
Circulating anti-retinal antibodies as immune markers in age-related macular degeneration
-
Patel N, Ohbayashi M, Nugent AK, et al. Circulating anti-retinal antibodies as immune markers in age-related macular degeneration. Immunology 2005;115:422-430.
-
(2005)
Immunology
, vol.115
, pp. 422-430
-
-
Patel, N.1
Ohbayashi, M.2
Nugent, A.K.3
-
11
-
-
67650519801
-
Assessing susceptibility to age-related macular degeneration with proteomic and genomic biomarkers
-
Gu J, Pauer GJ, Yue X, et al. Assessing susceptibility to age-related macular degeneration with proteomic and genomic biomarkers. Mol Cell Proteomics 2009;8:1338-1349.
-
(2009)
Mol Cell Proteomics
, vol.8
, pp. 1338-1349
-
-
Gu, J.1
Pauer, G.J.2
Yue, X.3
-
12
-
-
0025086052
-
Macrophages related to Bruch's membrane in age-related macular degeneration
-
Killingsworth MC, Sarks JP, Sarks SH. Macrophages related to Bruch's membrane in age-related macular degeneration. Eye 1990;4:613-621.
-
(1990)
Eye
, vol.4
, pp. 613-621
-
-
Killingsworth, M.C.1
Sarks, J.P.2
Sarks, S.H.3
-
15
-
-
33751004690
-
A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration
-
Yang Z, Camp NJ, Sun H, et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 2006;314:992-993.
-
(2006)
Science
, vol.314
, pp. 992-993
-
-
Yang, Z.1
Camp, N.J.2
Sun, H.3
-
16
-
-
36049042661
-
Avariant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration
-
Kanda A, Chen W, Othman M, et al. Avariant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc Natl Acad Sci USA 2007;104:16227-16232.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 16227-16232
-
-
Kanda, A.1
Chen, W.2
Othman, M.3
-
17
-
-
41849107208
-
Interleukin-8 promoter polymorphism-251A/T is a risk factor for age-related macular degeneration
-
Goverdhan SV, Ennis S, Hannan SR, et al. Interleukin-8 promoter polymorphism-251A/T is a risk factor for age-related macular degeneration. Br J Ophthalmol 2008;92: 537-540.
-
(2008)
Br J Ophthalmol
, vol.92
, pp. 537-540
-
-
Goverdhan, S.V.1
Ennis, S.2
Hannan, S.R.3
-
18
-
-
36749100977
-
PLEKHA1-LOC387715-HTRA1 polymorphisms and exudative age-related macular degeneration in the French population
-
Leveziel N, Souied EH, Richard F, et al. PLEKHA1-LOC387715-HTRA1 polymorphisms and exudative age-related macular degeneration in the French population. Mol Vis 2007;13:2153-2159.
-
(2007)
Mol Vis
, vol.13
, pp. 2153-2159
-
-
Leveziel, N.1
Souied, E.H.2
Richard, F.3
-
19
-
-
34548718285
-
Age-related macular degeneration and the immune response: Implications for therapy
-
Nussenblatt RB, Ferris F III. Age-related macular degeneration and the immune response: implications for therapy. Am J Ophthalmol 2007;144:618-626.
-
(2007)
Am J Ophthalmol
, vol.144
, pp. 618-626
-
-
Nussenblatt, R.B.1
Ferris III, F.2
-
20
-
-
59849104241
-
Molecular pathology of age-related macular degeneration
-
Ding X, Patel M, Chan CC. Molecular pathology of age-related macular degeneration. Prog Retin Eye Res 2009;28:1-18.
-
(2009)
Prog Retin Eye Res
, vol.28
, pp. 1-18
-
-
Ding, X.1
Patel, M.2
Chan, C.C.3
-
21
-
-
38949185692
-
Oxidative damage-induced inflammation initiates age-related macular degeneration
-
Hollyfield JG, Bonilha VL, Rayborn ME, et al. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med 2008;14:194-198.
-
(2008)
Nat Med
, vol.14
, pp. 194-198
-
-
Hollyfield, J.G.1
Bonilha, V.L.2
Rayborn, M.E.3
-
22
-
-
15044342651
-
Regression of neovascular age-related macular degeneration following infliximab therapy
-
Markomichelakis NN, Theodossiadis PG, Sfikakis PP. Regression of neovascular age-related macular degeneration following infliximab therapy. Am J Ophthalmol 2005;139: 537-540.
-
(2005)
Am J Ophthalmol
, vol.139
, pp. 537-540
-
-
Markomichelakis, N.N.1
Theodossiadis, P.G.2
Sfikakis, P.P.3
-
23
-
-
64349100107
-
Intravitreal administration of the anti-tumor necrosis factor agent infliximab for neovascular age-related macular degeneration
-
30 e1
-
Theodossiadis PG, Liarakos VS, Sfikakis PP, Vergados IA, Theodossiadis GP. Intravitreal administration of the anti-tumor necrosis factor agent infliximab for neovascular age-related macular degeneration. Am J Ophthalmol 2009;147:825-830, 30 e1.
-
(2009)
Am J Ophthalmol
, vol.147
, pp. 825-830
-
-
Theodossiadis, P.G.1
Liarakos, V.S.2
Sfikakis, P.P.3
Vergados, I.A.4
Theodossiadis, G.P.5
-
24
-
-
10744222484
-
Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: Long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration
-
Nussenblatt RB, Thompson DJ, Li Z, et al. Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration. J Autoimmun 2003;21:283-293.
-
(2003)
J Autoimmun
, vol.21
, pp. 283-293
-
-
Nussenblatt, R.B.1
Thompson, D.J.2
Li, Z.3
-
26
-
-
0038299000
-
Sirolimus: Its discovery, biological properties, and mechanism of action
-
Sehgal SN. Sirolimus: its discovery, biological properties, and mechanism of action. Transplant Proc 2003;35:S7-S14.
-
(2003)
Transplant Proc
, vol.35
-
-
Sehgal, S.N.1
-
27
-
-
0028858836
-
Synergistic effect of rapamycin and cyclosporin A in the treatment of experimental autoimmune uveoretinitis
-
Martin DF, DeBarge LR, Nussenblatt RB, Chan CC, Roberge FG. Synergistic effect of rapamycin and cyclosporin A in the treatment of experimental autoimmune uveoretinitis. J Immunol 1995;154:922-927.
-
(1995)
J Immunol
, vol.154
, pp. 922-927
-
-
Martin, D.F.1
Debarge, L.R.2
Nussenblatt, R.B.3
Chan, C.C.4
Roberge, F.G.5
-
28
-
-
0029004771
-
Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions
-
Scallon BJ, Moore MA, Trinh H, Knight DM, Ghrayeb J. Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions. Cytokine 1995;7:251-259.
-
(1995)
Cytokine
, vol.7
, pp. 251-259
-
-
Scallon, B.J.1
Moore, M.A.2
Trinh, H.3
Knight, D.M.4
Ghrayeb, J.5
-
29
-
-
67649386575
-
Age-related macular degeneration: An immunologically driven disease
-
Nussenblatt RB, Liu B, Li Z. Age-related macular degeneration: an immunologically driven disease. Curr Opin Investig Drugs 2009;10:434-442.
-
(2009)
Curr Opin Investig Drugs
, vol.10
, pp. 434-442
-
-
Nussenblatt, R.B.1
Liu, B.2
Li, Z.3
|